Bayesian approach to assessing population differences in genetic risk of disease with application to prostate cancer
PLOS Genetics · 2024
DOI: 10.1371/journal.pgen.1011212 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, 2024. Verfasst von Iain R Timmins und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom. Hauptthemen laut MEDLINE: Multifactorial Inheritance, Prostatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Population differences in risk of disease are common, but the potential genetic basis for these differences is not well understood. A standard approach is to compare genetic risk across populations by testing for mean differences in polygenic scores, but existing studies that use this approach do not account for statistical noise in effect estimates (i.e., the GWAS betas) that arise due to the finite sample size of GWAS training data. Here, we show using Bayesian polygenic score methods that the level of uncertainty in estimates of genetic risk differences across populations is highly dependent on the GWAS training sample size, the polygenicity (number of causal variants), and genetic distance (F ST ) between the populations considered. We derive a Wald test for formally assessing the difference in genetic risk across populations, which we show to have calibrated type 1 error rates under a simplified assumption that all SNPs are independent, which we achieve in practise using linkage disequilibrium (LD) pruning. We further provide closed-form expressions for assessing the uncertainty in estimates of relative genetic risk across populations under the special case of an infinitesimal genetic architecture. We suggest that for many complex traits and diseases, particularly those with more polygenic architectures, current GWAS sample sizes are insufficient to detect moderate differences in genetic risk across populations, though more substantial differences in relative genetic risk (relative risk > 1.5) can be detected. We show that conventional approaches that do not account for sampling error from the training sample, such as using a simple t -test, have very high type 1 error rates. When applying our approach to prostate cancer, we demonstrate a higher genetic risk in African Ancestry men, with lower risk in men of European followed by East Asian ancestry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom.
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
- Statistical Innovation, AstraZeneca, Cambridge, United Kingdom.
ORCID-Profile: Iain R Timmins
Förderung
- Medical Research Council
Zitieren
APA
Timmins, I. R., PRACTICAL Consortium, & Dudbridge, F. (2024). Bayesian approach to assessing population differences in genetic risk of disease with application to prostate cancer. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011212
Vancouver
Timmins IR, PRACTICAL Consortium, Dudbridge F. Bayesian approach to assessing population differences in genetic risk of disease with application to prostate cancer. PLOS Genetics. 2024. doi:10.1371/journal.pgen.1011212
BibTeX
@article{Timmins2024,
author = {Timmins, Iain R and PRACTICAL Consortium, PRACTICAL Consortium and Dudbridge, Frank},
title = {Bayesian approach to assessing population differences in genetic risk of disease with application to prostate cancer},
journal = {PLOS Genetics},
year = {2024},
doi = {10.1371/journal.pgen.1011212}
}
EUVIMED